TY  - GEN
AU  - Goksel,Tuncay
AU  - Hatipoglu,Osman Nuri
AU  - Ozturk,Can
AU  - Gorguner,Metin
AU  - Kiyik,Murat
AU  - Yilmaz,Ugur
AU  - Guzelant,Asuman
AU  - Tasbakan,Sezai
AU  - Tabakoglu,Erhan
AU  - Firat,Hikmet
AU  - Tutar,Umit
AU  - Cikrikicioglu,Sadettin
AU  - Akkoclu,Atila
AU  - Soyer,Serdar
AU  - Cakir,Ebru
AU  - Itil,Oya
AU  - Sanal,Salahattin
TI  - A prospective, multicentre clinical trial comparing cisplatin plus gemcitabine with cisplatin plus etoposide in patients with locally advanced and metastatic non-small cell lung cancer
SN  - 1323-7799
PY  - 2006///0207
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Cisplatin
KW  - Deoxycytidine
KW  - Drug Therapy, Combination
KW  - Etoposide
KW  - Female
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Prospective Studies
KW  - Survival Rate
KW  - Treatment Outcome
KW  - Turkey
KW  - Gemcitabine
N1  - Publication Type: Clinical Trial, Phase IV; Comparative Study; Journal Article; Multicenter Study
UR  - https://doi.org/10.1111/j.1440-1843.2005.00739.x
ER  -